Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-monthly intravenous C.E.R.A. for maintenance of haemoglobin in dialysis patients with chronic renal anaemia
2007-002380-27Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methoxy polyethylene glycol-epoetin beta in Uraemic Anaemia and chronic kidney disease (CKD), sponsored by Roche. Primary endpoint: Haemoglobin maintenance within target range during evaluation period. Started Jul 2007; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
Uraemic Anaemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on 2007-002380-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002380-27.